17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      CD4+ T Cells Targeting Dominant and Cryptic Epitopes from Bacillus anthracis Lethal Factor

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Anthrax is an endemic infection in many countries, particularly in the developing world. The causative agent, Bacillus anthracis, mediates disease through the secretion of binary exotoxins. Until recently, research into adaptive immunity targeting this bacterial pathogen has largely focused on the humoral response to these toxins. There is, however, growing recognition that cellular immune responses involving IFNγ producing CD4+ T cells also contribute significantly to a protective memory response. An established concept in adaptive immunity to infection is that during infection of host cells, new microbial epitopes may be revealed, leading to immune recognition of so called ‘cryptic’ or ‘subdominant’ epitopes. We analyzed the response to both cryptic and immunodominant T cell epitopes derived from the toxin component lethal factor and presented by a range of HLA-DR alleles. Using IFNγ-ELISpot assays we characterized epitopes that elicited a response following immunization with synthetic peptide and the whole protein and tested their capacities to bind purified HLA-DR molecules in vitro. We found that DR1 transgenics demonstrated T cell responses to a greater number of domain III cryptic epitopes than other HLA-DR transgenics, and that this pattern was repeated with the immunodominant epitopes, as a greater proportion of these epitopes induced a T cell response when presented within the context of the whole protein. Immunodominant epitopes LF 457-476 and LF 467-487 were found to induce a T cell response to the peptide, as well as to the whole native LF protein in DR1 and DR15, but not in DR4 transgenics. The analysis of Domain I revealed the presence of several unique cryptic epitopes all of which showed a strong to moderate relative binding affinity to HLA-DR4 molecules. However, none of the cryptic epitopes from either domain III or I displayed notably high binding affinities across all HLA-DR alleles assayed. These responses were influenced by the specific HLA alleles presenting the peptide, and imply that construction of future epitope string vaccines which are immunogenic across a wide range of HLA alleles could benefit from a combination of both cryptic and immunodominant anthrax epitopes.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: not found
          • Article: not found

          Anthrax.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.

            Immunization with myelin basic protein (MBP) induces experimental allergic encephalomyelitis (EAE), a prototype of CD4+ T-cell mediated autoimmune disease. In rodents, MBP-reactive T-cell clones are specific for a single, dominant determinant on MBP and use a highly restricted number of T-cell receptor genes. Accordingly, EAE has been prevented by various receptor-specific treatments, suggesting similar strategies may be useful for therapy of human autoimmune disease. Here we report that in (SJL x B10.PL)F1 mice, immune dominance of a single determinant, MBP:Ac1-11, is confined to the inductive phase of EAE. In mice with chronic EAE, several additional determinants of MBP in peptides 35-47, 81-100 and 121-140 recall proliferative responses. Most importantly, reactivity to the latter determinants was also detected after induction of EAE with MBP peptide Ac1-11 alone; this demonstrates priming by endogenous MBP determinants. Thus, determinants of MBP that are cryptic after primary immunization can become immunogenic in the course of EAE. Diversification of the autoreactive T-cell repertoire due to 'determinant spreading' has major implications for the pathogenesis of, and the therapeutic approach to, T-cell driven autoimmune disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Investigation of Bioterrorism-Related Anthrax, United States, 2001: Epidemiologic Findings

              In October 2001, the first inhalational anthrax case in the United States since 1976 was identified in a media company worker in Florida. A national investigation was initiated to identify additional cases and determine possible exposures to Bacillus anthracis. Surveillance was enhanced through health-care facilities, laboratories, and other means to identify cases, which were defined as clinically compatible illness with laboratory-confirmed B. anthracis infection. From October 4 to November 20, 2001, 22 cases of anthrax (11 inhalational, 11 cutaneous) were identified; 5 of the inhalational cases were fatal. Twenty (91%) case-patients were either mail handlers or were exposed to worksites where contaminated mail was processed or received. B. anthracis isolates from four powder-containing envelopes, 17 specimens from patients, and 106 environmental samples were indistinguishable by molecular subtyping. Illness and death occurred not only at targeted worksites, but also along the path of mail and in other settings. Continued vigilance for cases is needed among health-care providers and members of the public health and law enforcement communities.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Microbiol
                Front Microbiol
                Front. Microbiol.
                Frontiers in Microbiology
                Frontiers Media S.A.
                1664-302X
                05 January 2016
                2015
                : 6
                : 1506
                Affiliations
                [1] 1Avian Viral Immunology Group, The Pirbright Institute Pirbright, UK
                [2] 2Centre for Infection and Immunity, Queen’s University Belfast Belfast UK
                [3] 3Section of Infectious Diseases and Immunity, Department of Medicine, Imperial College London London, UK
                [4] 4Institute of Cellular Medicine, Newcastle University Newcastle upon Tyne, UK
                [5] 5Center for Biomedical Engineering and Technology, University of Maryland School of Medicine Baltimore, MD, USA
                [6] 6School of Pharmacy and Pharmaceutical Sciences, Cardiff University Cardiff, UK
                [7] 7Defence Science and Technology Laboratory Salisbury, UK
                [8] 8Service d’Ingénierie Moléculaire des Protéines, Insititut de Biologie et de Technologies de Saclay, Commiseriat à l’Energie Atomique, Gif Sur Yvette France
                Author notes

                Edited by: Tao Dong, University of Oxford, UK

                Reviewed by: Kirsten McCabe, Los Alamos National Laboratory, USA; Ram P. Kamal, Centers for Disease Control and Prevention, USA

                *Correspondence: Daniel M. Altmann, d.altmann@ 123456imperial.ac.uk

                This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology

                Article
                10.3389/fmicb.2015.01506
                4700811
                26779161
                161e26db-3400-42c1-afe9-7b77c9097e17
                Copyright © 2016 Ascough, Ingram, Chu, Musson, Moore, Gallagher, Baillie, Williamson, Robinson, Maillere, Boyton and Altmann.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 07 September 2015
                : 14 December 2015
                Page count
                Figures: 5, Tables: 2, Equations: 0, References: 49, Pages: 12, Words: 0
                Funding
                Funded by: National Institute of Allergy and Infectious Diseases 10.13039/100000060
                Award ID: (Contract HHSN266200400084C)
                Categories
                Microbiology
                Original Research

                Microbiology & Virology
                anthrax,lethal factor,epitope,cryptic,subdominant,immunodominant,hla,cd4+
                Microbiology & Virology
                anthrax, lethal factor, epitope, cryptic, subdominant, immunodominant, hla, cd4+

                Comments

                Comment on this article